An alkaline phosphatase immunochemically similar to placental alkaline phosphatase (EC 3.1.3.1) was purified from liver metastases of a giant-cell carcinoma of the lung. Some properties of its physical and chemical structure were determined and compared to those of purified placental alkaline phosphatase. The purified tumor phosphatase and the placental phosphatase were similar with regard to the following properties: (1) NH2-terminal sequence, (2) peptide map, (3) subunit molecular weight, and (4) isoelectric point. The physical properties and NH2-terminal sequence of alkaline phosplhatase isoenzyme of liver differed from the placental and the tumor enzyme. The data from the present study strongly support the hypothesis that the tumor and the placental alkaline phosphatases are products of the same gene.
Synthesis of proteins not associated with the cell of origin of the neoplasm has been reported in various human cancers (1) (2) (3) (4) . Many of these have properties characteristic of proteins normally synthesized by other cells. An hypothesis offered to account for the synthesis of these proteins is that derepression of the genome accompanies neoplastic transformation. This hypothesis predicts that the polypeptides synthesized ectopically in neoplastic cells are products of the same gene as the ones synthesized in the normal cell of origin.
One such ectopic protein that has frequently been associated with human neoplasms is an alkaline phosphatase (EC 3.1.3.1) with properties similar to the isoenzyme normally synthesized in the placenta by the trophoblast (5) . The placental isoenzyme can be distinguished from other organspecific alkaline phosphatase isoenzymes by its functional and structural properties, including heat stability, response to various inhibitors, electrophoretic mobility, and immunological reactivity (6) (7) (8) (9) . The neoplasm-associated alkaline phosphatase is immunochemically similar to the placental enzyme (5, (10) (11) (12) (13) . Recent studies have reported differences in heat stability at high pH and sensitivity to certain inhibitors between the placental and tumor-associated alkaline phosphatase (11, 12) . Moreover, immunological crossreactivity does not define molecular identity, since crossreactivity occurs between similar but not identical molecules (14, 15) . Clearly, a more detailed structural characterization is necessary to determine whether or not these proteins are similar in aminoAbbreviations: Dansyl, 1-dimethylaminonaphthalene-5-sulfonyl; TPCK, L-(1-tosylamido-2-phenyl) chloromethyl ketone. acid sequence and are indeed products of the same structural gene.
The present investigation reports the purification of an alkaline phosphatase from neoplastic tissue, and the comparison of several structural properties of this enzyme with the alkaline phosphatase normally synthesized in the placenta.
MATERIALS AND METHODS
Immunoassays. An immunochemical assay for specific and quantitative measurement of placental alkaline phosphatase has been described (8) . With this method no crossreactivity occurs between the placental enzyme and other organ-specific isoenzymes. Enzyme activity is measured by the cleavage of p-nitrophenol from p-nitrophenyl phosphate at optimum pH, 11.5, and 370.
Purification of Placental Alkaline Phosphatase. Alkaline phosphatase was extracted from human placentas and purified to homogeneity as described (8 (16) .
For smaller quantities electrofocusing was conducted in a Ushaped tube apparatus with a working volume of 11 ml (17) . Ampholine solutions at pH 3-10 and 3-6 were used.
Polyacrylamide-Gel Electrophoresis was done with a slab-gel apparatus similar to that described by Reid and Bieleski (18) . The mobility of the protein bands was measured relative to the tracking dye, bromphenol blue. Gels were fixed with 5% acetic acid in 50% methanol and stained with Coomassie blue.
The standard Tris-glycine buffer system with running pH 9.5 was used to follow enzyme purification and to compare mobilities of the active enzymes (19, 20) . Enzyme activity was determined by brief incubation of the slab in a solution of p-nitrophenyl phosphate. The yellow band of p-nitrophenol released by the enzyme was marked with razor cuts.
Molecular Weight Determinations. A discontinuous buffer system with sodium dodecyl sulfate was used to estimate and compare subunit molecular weights (21) . Bovine-serum albumin (68,000 molecular weight), carboxypeptidase A (34,300 molecular weight), and myoglobin (17,200 molecular weight) were used as molecular weight standards. Molecular weights were estimated by plotting the logarithm of the relative mobility against molecular weights of the standards.
Amino-Terminal Sequence Analysis. 1-Dimethylaminonaphthalene-5-sulphonyl (dansyl) end-group determination combined with stepwise Edman degradation was performed by methods designed for analysis of proteins on a nanomole scale (22) . Na dodecyl sulfate is used throughout the procedure to maintain protein solubility, and NaHCO3 buffer acts as an inorganic carrier in the precipitation of small amounts of protein with acetone. Dansyl residues were identified by chromatography on two-sided polyamide sheets. Samples were unequivocally identified by spotting the sample alone on one side of the sheet and the sample plus a selected marker mixture on the other side and cochromatographing them as described by Hartley (23) . Dansyl residues were made visible in a chromatograph viewer equipped with a short-wave ultraviolet light.
Dansyl Fingerprints. Proteins were dansylated by essentially the same procedure used for end-group determination, except that they were incubated with dansyl chloride for 60 min. Dansyl reagents were removed by acetone precipitation of the protein along with the NaHCO3 buffer.
The pellets were dissolved in 1% Na dodecyl sulfate and the pH was adjusted to 8.2 with CO2. The proteins were reduced with dithiothreitol and the sulfhydryls were carboxymethylated with sodium iodoacetate. Reagents were again removed by precipitating the protein with acetone. NaHCO3 was removed by washing the pellets with 20% trichloroacetic acid, 1 N HCl, and finally ethanol-ether (1:1).
The dry pellets were suspended in 0.05 M NH4HCO3 (pH 8.2) and digested with trypsin (Worthington, TPCK treated). Peptides were dried in a vacuum dessicator, dissolved in a small volume of electrophoresis buffer, and spotted on thin layers of silica gel on plastic (Eastman no. 6061). Two samples of peptides were applied on one plate to make mirrorimage maps (24) . Electrophoresis was done in a BrinkmannDesaga chamber with 8.8% formic acid for 3'/2 hr at 250 V at 15°. The sheets were cut between the peptides, and ascending chromatography was done in a Shandon chamber with the buffers indicated in the figure legends. 
RESULTS
Purification of Placental Alkaline Phosphatase. The enzyme eluted from the DEAE-cellulose column as a broad peak and shoulder (Fig. 1) . Slab gel electrophoresis in Tris-glycine buffer of samples taken across the peak showed a gradual increase in electrophoretic mobility from the early to the late eluting portions of the peak. Eluate from the column was pooled in two fractions, designated A and B, as indicated in Fig. 1 . Each fraction was further purified by chromatography on Sephadex G-200 and used in the subsequent comparative studies. The elution volume of enzyme from the Sephadex column was the same for both fractions A and B, indicating the approximate same molecular weight. The gel electrol)herogram in Fig. 4 shows the slight difference in mobility between the two purified fractions. This difference in mobility is an index of the microheterogeneity of the enzyme indicated by the broad elution profile in Fig. 1 .
Purification of Tumor Alkaline Phosphatase. Fig. 2 shows the elution pattern on DEAE-cellulose of alkaline phos- precipitated by the antiserum against placental phosphatase are shown. The remainder of the activity was precipitated by the antiserum prepared against liver alkaline phosphatase. There is substantial overlap in the elution from DEAE-cellulose of the tumor and liver alkaline phosphatase isoenzymes.
The peak fraction of alkaline phosphatase activity eluted from DEAE-cellulose (Fig. 2) was cut into three fractions for electrofocusing. Each fraction was electrofocused separately. Electrofocusing of the fraction contained in tubes [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] (Fig. 2) is shown in Fig. 3 . This fraction contained the greatest amount of liver isoenzyme (40-60%) mixed with tumor enzyme before electrofocusing. After electrofocusing, more than 96% of the alkaline phosphatase in the enzyme peak fraction was immunologically like the placental isoenzyme. Gel electrophoresis of the sample confirmed that liver alkaline phosphatase was no longer present in the tumor preparation. The apparent disappearance of liver alkaline phosphatase during isoelectric focusing was explained when liver enzyme was run alone. It has a pl lower than pH 3.8. It is either inactivated below this pH or the pI is so low that it migrates out of the gradient into the electrode buffer. This difference in pI between tumor and liver alkaline phosphatases allowed complete separation of these two isoenzymes. The isoelectric point of the enzyme peak shown in Fig. 3 Fig. 4 . Each preparation migrates as a single major protein band coincident with enzyme activity. The mobility of tumor alkaline phosphatase is slightly less than either fraction A or B. It has been previously shown that the mobility of liver isoenzyme is distinctly different from that of the placental enzyme (8) .
Molecular Weight Determinations. After Na dodecyl sulfategel electrophoresis, fractions A and B of placental alkaline phosphatase and tumor alkaline phosphatase each appears as a single major band (Fig. 4) . The relative mobility of each of these preparations is identical. The subunit molecular weight estimated by plotting the logarithm of the relative mobility of the three standards against their molecular weights is 64,000. Maps of fractions A and B in identical buffer systems showed a similar degree of peptide variation. These minor differences were not greater than differences seen when samples of identical enzyme preparations were taken through the procedure separately; therefore, the variation observed probably represents experimental variation rather than sequence variation.
DISCUSSION
The results of this investigation show that an alkaline phosphatase purified from neoplastic tissue and normal placental alkaline phosphatase are similar with regard to several structural parameters.
The isoelectric point of the tumor alkaline phosphatase averages pH 4.40 in these experiments. This is essentially the same as the pI of placental alkaline phosphatase, which is pH 4 .45.
The subunit molecular weights of fractions A and B of placental alkaline phosphatase and the tumor enzyme are identical. The value of 64,000 daltons estimated by Na dodecyl sulfate-gel electrophoresis is close to the value previously obtained by ultracentrifuge studies which showed placental alkaline phosphatase to be a dimer of about 120,000 daltons with subunits of identical molecular weight (25) . The tumor alkaline phosphatase elutes from Sephadex G-200 at the same volume as placental alkaline phosphatase, suggesting that it too is a dimer with subunits of identical molecular weight.
The amino-terminal sequences of the tumor and placental enzymes determined by the dansyl-Edman procedure are identical, differing from that of liver isoenzyme. Although this evidence is limited in extent, it is highly specific. The peptide structure from the dansyl fingerprints allows a more extensive comparison of the amino-acid sequences. This procedure showed similar peptide maps of the tumor and the placental enzymes.
The similarities in structure between tumor and placental enzymes shown in the NH2-terminal sequence and peptidemapping studies highly suggest that the two enzymes are identical in their polypeptide structure. The similarity in other physical and chemical properties provides substantiating evidence for this identity. By contrast, the different NHr2 terminal sequence for the liver enzyme is strong evidence that it is a different protein.
The only variation that we observed between tumor and placental enzymes was a slight difference in mobility after Tris-glycine gel electrophoresis. The difference between fraction A of placental alkaline phosphatase and the tumor enzyme is about the same as the difference between fractions A and B of placental alkaline phosphatase. The difference is so slight that we did not notice it when these samples were subjected to electrophoresis on a standard gel apparatus with samples on separate columns rather than on a slab. Genetic alleles of placental alkaline phosphatase have been reported (26) , and this is a possible explanation for the variation in electrophoretic mobility. None of our other data indicates their presence. However, some amino-acid substitutions in the tumor alkaline phosphatase might not be detected in the present investigations. In view of the experimental evidence showing similarity in peptide structure of the tumor and placental enzymes, the most likely explanation for the electrophoretic difference is from epigenetic modification of the enzyme. Placental alkaline phosphatase is a glycoprotein (9) , and this same kind of electrophoretic microheterogeneity has been observed with other glycoproteins (27, 28) . Similarly, modification of amino-acid side chains of proteins also affects electrophoretic mobility (29) .
The results reported here support the hypothesis that the alkaline phosphatase synthesized in neoplastic tissue and in the placenta are products of the same structural gene, and that this gene, which is normally expressed in the placenta, is derepressed in some neoplasms.
